Adverse Effects of Doxorubicin and Its Metabolic Product on Cardiac RyR2 and SERCA2A
The use of anthracycline chemotherapeutic drugs is restricted owing to potentially fatal cardiotoxic side effects. It has been hypothesized that anthracycline metabolites have a primary role in this cardiac dysfunction; however, information on themolecular interactions of these compounds in the heart is scarce. Here we provide novel evidence that doxorubicin and its metabolite, doxorubicinol, bind to the cardiac ryanodine receptor (RyR2) and to the sarco/endoplasmic reticulumCa2+ATPase...[Show more]
|Collections||ANU Research Publications|
|01_Hanna_Adverse_Effects_of_Doxorubicin_2014.pdf||1.06 MB||Adobe PDF||Request a copy|
Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.